CPI-1429

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCPI-1429

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRenovis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesRenovis

Active IndicationsN/A

Inactive IndicationsInflammatory Bowel Diseases

ATC CodeN/A